There was ongoing research into the potential benefits of various natural remedies and traditional medicinal herbs in the treatment or prevention of COVID-19, including Andrographis paniculata, commonly known as the “king of bitters.” This plant has been used in traditional medicine in Asia for its anti-inflammatory, antiviral, and immune-boosting properties.
Andrographis paniculata is a medicinal plant that has been used for centuries in traditional medicine to treat a variety of ailments, including fever, colds, and respiratory infections. In recent years, there has been growing interest in the potential of andrographis to treat COVID-19.
Andrographis boasts numerous active constituents, including andrographolide, recognized for their antiviral, antibacterial, and anti-inflammatory effects. Laboratory research has indicated that andrographolide may obstruct the replication process of SARS-CoV-2, the virus responsible for COVID-19. Moreover, Andrographis is known to fortify the immune system, contributing to increased protection against infections.
There are a number of clinical studies that have been conducted to investigate the efficacy of andrographis for COVID-19. A small, randomized controlled trial published in 2021 found that andrographis was effective in reducing the severity of COVID-19 symptoms. In the study, participants who received andrographis had a shorter duration of illness and were less likely to require hospitalization than those who received a placebo.
A separate randomized controlled trial carried out in 2022 demonstrated that Andrographis successfully impeded the progression of COVID-19 from a mild to severe condition. Participants in this study who were administered Andrographis were less likely to develop pneumonia or acute respiratory distress syndrome compared to placebo recipients.
Despite these encouraging results, additional research is necessary to ascertain the efficacy and safety of Andrographis for COVID-19 treatment. Andrographis is generally regarded as safe when used as recommended but may cause side effects such as nausea, vomiting, and diarrhea. It’s crucial to consult your doctor before starting Andrographis, particularly if you have pre-existing health conditions.
If you’re contemplating using Andrographis for COVID-19 treatment, it’s crucial to procure a superior quality product from a trustworthy source. Andrographis supplements are not FDA-regulated, so it’s vital to ensure the product you purchase contains the active ingredients listed on the label.
Here are some tips for choosing a high-quality andrographis supplement:
- Look for a product that is made from 100% Andrographis paniculata extract.
- Make sure the product is standardized to contain a certain amount of andrographolide, the active ingredient in andrographis.
- Choose a product that is manufactured in a GMP-certified facility.
- Read the reviews of the product before you buy it.
If you are taking andrographis for COVID-19, it is important to talk to your doctor about the best dosage for you. The recommended dosage of andrographis for COVID-19 is 450-600 mg per day, taken in divided doses. You should not take andrographis for more than 10 days without talking to your doctor.